Ocular Therapeutix (OCUL) Stock: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$6.61
0.13 (2.01%)
▲
5d:
-10.43%
30d:
-33.9%
90d:
-22.28%
HOLD
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 03, 2026
10d
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OCUL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OCUL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $6.61, which is considered oversold relative to its 30-day fair value range of $6.76 to $9.62.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $6.00, while resistance sits at $7.75.
Market Sentiment: OCUL scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $26.00 (+293.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $6.00, while resistance sits at $7.75.
Market Sentiment: OCUL scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $26.00 (+293.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.76 -
$9.62
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding OCUL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 293.3% below Wall St target ($26.00)
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-10.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$6.76 -
$9.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.00
Resistance Level
$7.75
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.47
Wall Street Target
$26.00
(+293.3%)
Revenue Growth (YoY)
0.1%
Share & Embed Analysis
Last updated: October 22, 2026 9:09 PM ET
Data refreshes hourly during market hours. Next update: 10:09 PM
Data refreshes hourly during market hours. Next update: 10:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 49 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 39 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 70 BUY |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
